Health committee  Debbie is our resident expert; she's a living example of the Edmonton Protocol. A number of advances have been made in the cell therapy arena in terms of the ability to regenerate insulin-producing cells outside of an individual. The traditional sources of cells are being looke

Health committee  There has been work done on both the internal and external devices. The prevailing enterprise right now is on external devices. There are some additional challenges around implantable devices. First and foremost is that you have to be able to refill the pump component of the arti

Health committee  It would be speculation on my part—and I'm happy to try to speculate a little bit for you—but there are several companies working on it right now. Within JDRF trials and testing we have this working in a hospital environment, so in a very controlled environment. The work that ne

Health committee  That's the goal right now.

Health committee  In essence, it would be a more sophisticated version of that pump and a continuous glucose monitor. Maksim, you're not wearing your CGM right now, are you? You're wearing your CGM, Marley. That pump has a continuous glucose monitor connected to it. So the tubing you see is

Health committee  The University of Alberta is the Edmonton Protocol. The artificial pancreas project has actually been worked on by many corporations and many institutions worldwide. In our trial network, we are working on parts of that too. That's taking an algorithm that can take those glucose

Health committee  The Edmonton Protocol is the islet cell transplant. That's taking cells from a cadaveric pancreas and transplanting those into an individual who has type 1 diabetes.

Health committee  It's a separate process.

Health committee  Canada remains very much a leader. It is a competitive space for sure, especially in the device market, because those are the treatments that are closest to market, if you like, right now and where it's developing, and there are big international device players that are working t

Health committee  Yes, very well.

Health committee  Certainly. Some of this is derived from estimates, but it is estimated that diabetes costs the Canadian health care system at present in excess of $12 billion a year. As you know, as the health committee, that's a significant portion of the budget. Type 1 diabetes presents an ex

Health committee  Of the nine clinical trials that were launched against the target of three—so we're very pleased that we could over-deliver on that front—the first trial, which I spoke to briefly, Bruce Perkins' trial at the University Health Network in Toronto, has finished enrollment and is ju

Health committee  Absolutely. Diabetes generally—and type 1 diabetes—has benefited incredibly over the last few years from advances in technologies, some of which you've heard about today from the kids providing their testimony, with both insulin pumps and continuous glucose monitoring. The JDRF

Health committee  At present, five of the nine trials in the CCTN are focused on elements of the artificial pancreas. In fact, in a pure laboratory environment at the moment, a closed-loop artificial pancreas is being tested today. To move that to market will take additional investment in clinica

Health committee  Today is to seek your continued support of CCTN here in Ontario, where appropriate, but also to expand it across Canada, to broaden the patient cohort and the patient base who'd have access to the technologies, and give our researchers out there in the Canadian community the oppo